Extract of north American ginseng (panax quinquefolius), administered to leukemic, juvenile mice extends their life span

Journal of Complementary and Integrative Medicine

Volumn 8, Issue 1, 2011, Pages

  Miller, Sandra C ^a   Delorme, Danielle ^a   Shan, Jacqueline J ^b  

^a MCGILL UNIVERSITY   (Canada)

^b Afexa Life Sciences Inc   (Canada)

Author keywords

ginseng; immune cells; leukemia; youth

Indexed keywords

CVT E002; GINSENG EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; LEUKEMIA; LEUKEMIA CELL; LIFESPAN; LOW DRUG DOSE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAPERITONEAL; LEUKEMIA; MALE; MICE; MICE, INBRED DBA; NORTH AMERICA; PANAX; PLANT EXTRACTS;

EID: 79952327489     PISSN: 15533840     EISSN: None     Source Type: Journal    
DOI: 10.2202/1553-3840.1315     Document Type: Article

References (21)

1. Argyris, B.F. (1981) Suppressor factor produced by neonatal mouse spleen cells. Cell Immunol. 62: 412-424. (Pubitemid 11049244)
2. Brousseau, M., Miller, S.C. (2005) Enhancement of natural killer cells and increased survival of aging mice fed daily Echinacea root extract from youth. Biogerontol. 6: 157-163. (Pubitemid 41131165)
3. Calkins, C.E., Stutman, O. (1978) Changes in suppressor mechanisms during post-natal development in mice. J. Exp. Med. 147:87-97. (Pubitemid 8250809)
4. Garwicz, S. (2000) Second malignant neoplasms after cancer in childhood and adolescence: A population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int. J. Cancer 88(4): 672-678
5. Herberman, R.B, Nunn, M.E., Larvin, D.H. (1975) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 16:216-229.
6. Hertell-Wulff, B., Strober, S. (1988) Immunosuppressive lymphokines derived from natural suppressor cells. J. Immunol. 240:2633-2638.
7. Holan, V., Lipoldova, M., Zajicova, A. (1991) Immunological nonreactivity of newborn mice: Immaturity of T cells and selective action of neonatal suppressor cells. Cell. Immunol. 137:216-223.
8. Keissling, R., Klein, E., Pross, H., et al. (1975) Natural killer cells in the mouse. II Cytotoxic cells with specificity for mouse Maloney leukemia cells. Characteristics of the killer cell. Eur. J. Immunol. 5:117-121.
9. Kleinerman, R.A., Tucker, M.A., Tarone, R.E., Abramson, D.H., Seddon, J.M., Stovall, M., Li, F.P., Fraumeni , J.F. Jr. (2005) Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: A extended followup. J. Clin. Oncol. 23: 2272-2279. (Pubitemid 46218720)
10. Mahoney, M.X., Currier, N.L., Miller, S.C. (1998) Natural killer cell levels in older adult mice are gender-dependent: Thyroxin is a gender-independent natural killer cell stimulant. Nat. Immun. 16:165-174. (Pubitemid 29271727)
11. Miller, S.C., Delorme, D. (2008) An extract from North American ginseng stimulates spontaneous immunity in infant mice: Sustained, augmented immunity in adulthood long after withdrawal of the extract. J. Comp. Integr. Med. 5(1): Http://www.bepress.com/jcim/vol5/iss1/6
12. Miller, S.C., Delorme, D., Shan, J.J. (2009) CVT E002 stimulates the immune system and extends the life span of mice bearing a tumor of viral origin. J. Soc. Integ. Oncol. 7(4): 127-136.
13. Neglia, J.P., Friedman, D.L., Yasui, Y., Mertens, A.C., Hammond, S., Stovall, M., Donaldson, S.S., Meadows, A.T., Robison, L.L. (2001) Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study. JNCI 93(8): 618-629. (Pubitemid 32409629)
14. Pukkala, E., van Leeuwen, F.E., Holowaty, E.J., Andersson, M., Wiklund, T., Joensuu, T., van't Veer, M.B., Stoval, M.M., Gospodarowicz, M., Travis, L.B. (2002) Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J. Clin. Onco. 20:3484-3494.
15. Riccardi, C., Barlozzari, T., Santoni, A., Herberman, H.B. Cesarini, C. (1981) Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors. J. Immunol. 126:1284-1289. (Pubitemid 11149211)
16. Shan, J.J., Rodgers, K.M., Lai, C.T., Sutherland, S.K. (2007) Challenges in Natural Health Product Research: The importance of standardization. Proc. West. Pharmacol. Soc. 50:24-30.
17. Sherwin, W.K., Rowlands, D.T. (1975) Determinants of the hierarchy of humoral immune responsiveness during ontogeny. J. Immunol. 115:1549-1554.
18. Spear, P.G., Edelman, G. (1974) Maturation of the humoral immune response in mice. J. Exp. Med. 139:249-263.
19. Sun, L.Z-Y., Currier, N.L., Miller, S.C. (1999) The American Coneflower: A prophylactic role involving nonspecific immunity. J. Alt. Comp. Med. 5(5):437-446. (Pubitemid 29489699)
20. Velardi, A., Cooper, M.D. (1984) An immunofluorescence analysis of the ontogeny of myeloid, T, and B lineage cells in the mouse hemopoietic tissues. J. Immunol. 133:672-677. (Pubitemid 14093449)
21. Wang, M, Guilbert, L.J., Ling, L., Li, J., Wu, Y., Xu, S., Pang, P., Shan, J.J. (2001) Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax Quinquefolium). J. Pharm. Pharmacol. 53(11):1515-1523. (Pubitemid 33064541)